Industry Partners

MPN News

• CALR Mutant MPN possible Disease Model of Cancer Immuno-editing
  Authors: Morten Orebo Holmström, Sabrina Cordua, Vibe Skov, Lasse Kjær, Niels Pallisgaard, Christina Ellervik, Hans Carl Hasselbalch, Mads Hald Andersen Evidence of immune elimination, immuno-editing and […] The post CALR Mutant MPN possible Disease Model of Cancer Immuno-editing appeared first on MPN Cancer Connection.
• Patient Focused Clinical Trials will Improve Next Generation Drugs
  Improving the next generation of drugs through patient-centric design for clinical trials by Dr. Richard Ghalie (Senior VP for Clinical Development at MEI Pharma) When a […] The post Patient Focused Clinical Trials will Improve Next Generation Drugs appeared first on MPN Cancer Connection.
• Curcumin induces apoptosis in JAK2‐mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways
  Open Access Article – Petiti J, Rosso V, Lo Iacono M, et al. Curcumin induces apoptosis in JAK2‐mutated cells by the inhibition of JAK2/STAT and mTORC1 […] The post Curcumin induces apoptosis in JAK2‐mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways appeared first on MPN Cancer Connection.
• Walking Pace Predicts Clinical Outcomes in Older Adults with Blood Cancers
  Slower walking pace linked to a higher likelihood of death and hospital visits; Researchers say gait speed should be used along with other vital signs to […] The post Walking Pace Predicts Clinical Outcomes in Older Adults with Blood Cancers appeared first on MPN Cancer Connection.